BIODELIVERY SCIENCES INTL (BDSI)

Common Stock

5.59  0 (-0.09%)

After market: 5.6 +0.01 (+0.18%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
111.4M
100.36%		156.5M
40.48%		166.703M
6.52%		206.554M
EBITDA
YoY % growth
12.53M
170.79%		40.52M
223.38%		44.548M
9.94%		N/AN/AN/AN/A
EBIT
YoY % growth
3.7M
115.68%		33M
791.89%		37.124M
12.50%		N/AN/AN/AN/A
Operating Margin
3.32%21.09%22.27%N/AN/AN/AN/A
EPS
YoY % growth
0.000.250.83
232.00%		0.35

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		0.07
Revenue
Q2Q % growth		49.303M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q4 2021
Q2Q % growth		 0.62
520.00%		0.020.602,432.68%
Q3 2021
Q2Q % growth		 0.07
-22.22%		0.060.0124.78%
Q2 2021
Q2Q % growth		 0.09
800.00%		0.050.0485.76%
Q1 2021
Q2Q % growth		 0.05 0.07-0.02-27.91%
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q4 2021
Q2Q % growth		 43.154M
2.33%		42.689M464.817K1.09%
Q3 2021
Q2Q % growth		 41.092M
4.19%		42.877M-1.785M-4.16%
Q2 2021
Q2Q % growth		 41.439M
13.28%		42.858M-1.419M-3.31%
Q1 2021
Q2Q % growth		 41.02M
7.16%		42.163M-1.143M-2.71%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A